HomeMarkets overviewSharesGlaxoSmithKline PLC

Trade GlaxoSmithKline PLC - GSKl CFD

Market is not available at the momentMarket information is presented
as of 2026-07-27T15:25:19+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.0446
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
£1,000.00
Overnight funding adjustment
Charges from full value of position
-0.02127 %
(-£4.25)

Trade size with leverage ~ £20,000.00

Money from leverage ~ £19,000.00


-0.02127%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
£1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000648 %
(-£0.13)

Trade size with leverage ~ £20,000.00

Money from leverage ~ £19,000.00


-0.00065%
Overnight funding adjustment time21:00 (UTC)
CurrencyGBP
Min traded quantity1
Margin5.00%
Stock exchangeGreat Britain
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close19.2307
Open19.3706
1-Year Change39.11%
Day's Range19.3506 - 19.7652

Trade GlaxoSmithKline PLC - GSKl

What is GSK (GSKl)?

GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, London. It is one of the world's largest pharmaceutical companies, engaged in the research, development, and manufacturing of a broad range of pharmaceutical products, vaccines, and consumer healthcare products. The company's operations span multiple therapeutic areas including respiratory, oncology, immunology, and infectious diseases. GlaxoSmithKline has a significant presence in both prescription medicines and vaccines, contributing to global health initiatives. The company also focuses on developing treatments for chronic diseases and conditions with high unmet medical needs. It operates through various business segments and maintains a global footprint with research facilities, manufacturing sites, and commercial operations across numerous countries. GlaxoSmithKline is involved in collaborations and partnerships to advance scientific innovation and improve patient outcomes. The company emphasizes sustainability and corporate responsibility in its operations, aiming to address healthcare challenges worldwide while adhering to regulatory standards and ethical practices.

GSK Stock Price Today: Live Overview

The price today is shaped by current trades, with GSK trading at £19.7498. Price movements have ranged from £19.2506 to £19.7702, with a daily percentage change of +2.7548%.

FAQ: GSK (GSKl)

What is the current price of GSKl stock?

GSK's current price is £19.7498.

Does GSKl pay dividends?

GSK pays dividends.

Does GSKl have a formal corporate presence or regional headquarters in the UAE?

GSK has an official regional office in Dubai Internet City, UAE.

What is GSKl best known for?

GSK is most famous for its pharmaceutical products and vaccines.

What assets are typically shown together with GSKl?

Commonly shown alongside GSKl: Norsk Hydro, JGC Holdings Corporation, ICG Enterprise Trust plc

Latest shares articles

GlaxoSmithKline stock forecast 2025-2050
GlaxoSmithKline stock forecast 2025-2050: Third-party GSK price target
GlaxoSmithKline (GSK) is a leading British multinational pharmaceutical and biotechnology company, focused on vaccines, and specialty medicines.
15:42, 28 August 2025
Microsoft sign outside offices
Microsoft stock forecast: AI spending and margin pressure
Microsoft shares remain in focus as investors assess its planned $190bn AI capital expenditure and the potential impact on near-term margins. Explore third-party MSFT price targets and technical analysis. Past performance is not a reliable indicator of future results.
3 hours ago
BYD Company stock forecast: Third-party price targets
BYD Company stock forecast: Record exports offset domestic weakness
BYD’s June sales showed a second month of annual growth, as record overseas exports partly offset a 22% decline in domestic sales. Explore third-party 1211 price targets and technical analysis. Past performance is not a reliable indicator of future results.
4 hours ago
AMD stock forecast: Can the tech giant reverse the downtrend?
AMD stock forecast: Q2 earnings, AI 2026 roadmap
AMD designs processors and graphics chips for data centres, PCs and gaming, and outlined its latest AI roadmap at Advancing AI 2026 ahead of Q2 earnings on 4 August. Explore third-party Advanced Micro Devices targets and technicals. Past performance is not a reliable indicator of future results.
4 hours ago
Related News
Reuters NewsEurope
06:00 (UTC), 24 July 2026
AstraZeneca 'magic' faces rare test after trial failure, share slide
Reuters NewsEurope
16:45 (UTC), 22 July 2026
US FDA approves GSK's lung cancer drug
Public TechnologiesEurope
16:38 (UTC), 22 July 2026
FDA approves GSK’s Jideytro for previously treated ROS1-positive NSCLC
Reuters NewsEurope
16:30 (UTC), 22 July 2026
US FDA approves GSK's lung cancer drug
Reuters NewsEurope
16:24 (UTC), 22 July 2026
GSK Says Jideytro Approved In Us For Certain Lung Cancers
Public TechnologiesEurope
06:14 (UTC), 20 July 2026
EMA accepts GSK submission to add single-dose Bexsero booster for ages 10+
Reuters NewsEurope
13:34 (UTC), 17 July 2026
GSK To Re-Appoint Deloitte As External Auditor From FY Ending 2028

User feedback and ratings

2025-07-01
Victor Flemming Nandwa Søder

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-07-01
Perry Reineke

I'm learning the basics of stock investing. This platform is clear and pretty good. I've been using it for over 6 months.

2025-06-29
proinpro

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

2025-06-27
Gio Gvazava

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-27
Douglas

Deposits and withdrawals work without issues. Very low spreads. No noticeable fees. Easy to follow.

2025-06-22
Jean A.

The app is built to make options and figures easy to understand, great for beginners and intermediate traders. Demo accounts are simple to set up. 100:1 leverage is available.

2025-06-19
foobarbeer

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-06-19
Casaubon70

Love the TV integration. Makes traders life smooth and comfortable.

2025-06-19
dgogidze7

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-05-30
Brigman

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-05-24
Radioilluminati

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-05-20
GemzT

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
dmjnoor

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-03-24
Debbie P

The best trading company I've found so far and so easy to use.

2025-02-06
Nouman Butt

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

Showing our 4 & 5 star reviews.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start trading